301 related articles for article (PubMed ID: 18209199)
1. What can we learn from failed neuropathic pain trials?
Polydefkis M; Raja SN
Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
[No Abstract] [Full Text] [Related]
2. Toward a definition of pharmacoresistant neuropathic pain.
Hansson PT; Attal N; Baron R; Cruccu G
Eur J Pain; 2009 May; 13(5):439-40. PubMed ID: 19324579
[No Abstract] [Full Text] [Related]
3. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
Katz J; Finnerup NB; Dworkin RH
Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for neuropathic pain.
Jackson KC
Pain Pract; 2006 Mar; 6(1):27-33. PubMed ID: 17309706
[TBL] [Abstract][Full Text] [Related]
5. Neuropathic pain: evidence matters.
McQuay HJ
Eur J Pain; 2002; 6 Suppl A():11-8. PubMed ID: 11888235
[TBL] [Abstract][Full Text] [Related]
6. Neural modulation by blocks and infusions.
Varrassi G; Paladini A; Marinangeli F; Racz G
Pain Pract; 2006 Mar; 6(1):34-8. PubMed ID: 17309707
[TBL] [Abstract][Full Text] [Related]
7. Neuropathic pain in leprosy.
Haanpää M; Lockwood DN; Hietaharju A
Lepr Rev; 2004 Mar; 75(1):7-18. PubMed ID: 15072122
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of neuropathic pain and their implications for the design of clinical trials.
Rowbotham MC
Neurology; 2005 Dec; 65(12 Suppl 4):S66-73. PubMed ID: 16385106
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends in the management of neuropathic pain.
McCleane G
Expert Rev Neurother; 2005 Sep; 5(5):617-23. PubMed ID: 16162085
[TBL] [Abstract][Full Text] [Related]
10. Painful peripheral neuropathy and its nonsurgical treatment.
Wolfe GI; Trivedi JR
Muscle Nerve; 2004 Jul; 30(1):3-19. PubMed ID: 15221874
[TBL] [Abstract][Full Text] [Related]
11. The management of neuropathic pain in cancer: clinical guidelines for the use of adjuvant analgesics.
George RM; Ahmedzai SH
Indian J Cancer; 2000 Mar; 37(1):4-9. PubMed ID: 11261235
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency procedures.
Racz GB; Ruiz-Lopez R
Pain Pract; 2006 Mar; 6(1):46-50. PubMed ID: 17309709
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
14. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.
Dworkin RH; Katz J; Gitlin MJ
Neurology; 2005 Dec; 65(12 Suppl 4):S7-19. PubMed ID: 16385107
[TBL] [Abstract][Full Text] [Related]
15. [Pain in peripheral neuropathies: physiopathology, clinical evaluation and medical management].
Danziger N
Rev Neurol (Paris); 2001 Dec; 157(12):1565-9. PubMed ID: 11924458
[No Abstract] [Full Text] [Related]
16. Molecular mechanism of neuropathic pain.
Ueda H; Rashid MH
Drug News Perspect; 2003 Nov; 16(9):605-13. PubMed ID: 14702142
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine decreases the pain feeling in healthy participants.
Arnold P; Vuadens P; Kuntzer T; Gobelet C; Deriaz O
Clin J Pain; 2008 Feb; 24(2):116-9. PubMed ID: 18209516
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?
Vo T; Rice ASC; Dworkin RH
Pain; 2009 Jun; 143(3):169-171. PubMed ID: 19362418
[No Abstract] [Full Text] [Related]
19. [Peripheral neuropathic pain and epilepsy].
Krankenpfl J; 2004; 42(7-10):219-20. PubMed ID: 15675385
[No Abstract] [Full Text] [Related]
20. Lamotrigine for neuropathic pain.
Eisenberg E; Shifrin A; Krivoy N
Expert Rev Neurother; 2005 Nov; 5(6):729-35. PubMed ID: 16274331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
